Close

Ratings by Ladenburg Thalmann (Aydin Huseynov)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/15/2022 SELLAS Life Sciences Group SLS Maintain Buy
(N/A)
 
 
  Details
8/3/2022 Alterity Therapeutics ATHE New Coverage Buy
(N/A)
0.60
(0.63)
5% Details
7/27/2022 Anebulo Pharmaceuticals ANEB New Coverage Buy
(N/A)
3.05
(3.69)
20.98% Details
7/13/2022 Nuvectis Pharma NVCT New Coverage Buy
(N/A)
12.69
(8.79)
-30.73% Details
6/13/2022 Aileron Therapeutics Inc ALRN New Coverage Buy
(N/A)
0.41
(0.22)
-46.34% Details
5/11/2022 Calithera Biosciences CALA Maintain Buy
(N/A)
 
 
  Details
5/6/2022 Quoin Pharmaceuticals QNRX New Coverage Buy
(N/A)
0.81
(4.97)
513.58% Details
5/2/2022 Annovis Bio Inc. ANVS New Coverage Buy
(N/A)
9.44
(11.75)
24.47% Details
4/22/2022 Cognition Therapeutics CGTX New Coverage Buy
(N/A)
3.10
(2.13)
-31.29% Details
4/4/2022 SELLAS Life Sciences Group SLS Maintain Buy
(N/A)
 
 
  Details
4/1/2022 Calithera Biosciences CALA Maintain Buy
(N/A)
 
 
  Details
3/15/2022 Compass Therapeutics CMPX New Coverage Buy
(N/A)
1.44
(3.01)
109.03% Details
3/8/2022 Spruce Biosciences, Inc. SPRB New Coverage Buy
(N/A)
1.88
(2.07)
10.11% Details
3/1/2022 NextCure Inc. NXTC New Coverage Buy
(N/A)
4.90
(4.86)
-0.82% Details
2/16/2022 Bellicum Pharmaceuticals BLCM New Coverage Buy
(N/A)
1.45
(1.48)
2.07% Details
2/7/2022 SELLAS Life Sciences Group SLS New Coverage Buy
(N/A)
5.41
(3.30)
-39% Details
2/2/2022 Palisade Bio Inc. PALI New Coverage Buy
(N/A)
1.23
(0.17)
-86.18% Details
1/31/2022 Calithera Biosciences CALA New Coverage Buy
(N/A)
0.42
(4.90)
1066.67% Details